Lenvatinib Mesylate and Pramipexole Extended-Release Tablets
Determining the interaction of Lenvatinib Mesylate and Pramipexole Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: pramipexole
Brand name: Mirapex, Mirapex ER
Synonyms: Pramipexole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Pramipexole Tablets
- Lenvatinib Mesylate-Pramlintide
- Lenvatinib Mesylate-Pramlintide Acetate
- Lenvatinib Mesylate-Pramlintide Subcutaneous
- Lenvatinib Mesylate-Pramosone
- Lenvatinib Mesylate-Pramosone Cream
- Pramipexole Extended-Release Tablets-Lenvima
- Pramipexole Extended-Release Tablets-Lenvima (14 MG Daily Dose)
- Pramipexole Extended-Release Tablets-Lenvima (18 MG Daily Dose)
- Pramipexole Extended-Release Tablets-Lenvima (20 MG Daily Dose)
- Pramipexole Extended-Release Tablets-Lenvima (24 MG Daily Dose)
- Pramipexole Extended-Release Tablets-Lenvima (8 MG Daily Dose)